CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Noncontrolling Interest, Increase from Equity Issuance or Sale of Parent Equity Interest (Deprecated 2013-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Noncontrolling Interest, Increase from Equity Issuance or Sale of Parent Equity Interest (Deprecated 2013-01-31) of -$4.00 million for the 12-month period ending 2010-12-25, per its 10-K filed 2013-02-27.
Discontinued › Notes
us-gaap:MinorityInterestIncreaseFromStockIssuance · last filed 2013-02-27
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, increase from equity issuance or sale of parent equity interest (deprecated 2013-01-31) for fiscal 2010 was -$4.00M.
| Period end | Noncontrolling Interest, Increase from Equity Issuance or Sale of Parent Equity Interest (Deprecated 2013-01-31) 12 month |
|---|---|
| 2010-12-25 | -$4.00M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |